As Omnibus Deadline Looms, Brands' Share Of Part D Donut-Hole Costs Could Be Lowered

Brand drug lobbyists say there is a decent chance Congress will lower drug companies’ share of Medicare Part D donut-hole costs by 5 percent to 6 percent as lawmakers could provide that much relief without increasing the deficit due to an updated estimate by the Congressional Budget Office, though drug makers are unlikely to get more than that because lawmakers don’t want to negotiate offsets. Industry’s goal is to use appropriations legislation to dial back the drug industry’s share of...